American National Bank & Trust’s Quest Diagnostics DGX Stock Holding History

American National Bank & Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86M	Sell	8,773 -169	-2%	-$33.2K	0.16%	76
2026 Q1	$1.75M	Sell	8,942 -214	-2%	-$41.6K	0.17%	72
2025 Q4	$1.59M	Sell	9,156 -958	-9%	-$174K	0.15%	75
2025 Q3	$1.93M	Buy	10,114 +1,202	+13%	+$213K	0.19%	68
2025 Q2	$1.6M	Sell	8,912 -650	-7%	-$113K	0.16%	78
2025 Q1	$1.62M	Buy	+9,562	New	+$1.57M	0.18%	72
2024 Q3	–	Sell	-23	Closed	-$3.15K	–	492
2024 Q2	$3.15K	Buy	+23	New	+$3.15K	﹤0.01%	506

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SIC

Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

American National Bank & Trust's DGX Position: Q2 2026 in Review

American National Bank & Trust reduced its Quest Diagnostics (DGX) stake by 1.9% in Q2 2026, selling an estimated $33.2K and leaving 8,773 shares worth $1.86M. The position accounts for 0.16% of the portfolio, ranked #76.

American National Bank & Trust first reported a position in DGX in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.93M in Q3 2025. 353 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

American National Bank & Trust held 8,773 shares of Quest Diagnostics worth $1.86M as of Q2 2026.
American National Bank & Trust sold 169 Quest Diagnostics shares in Q2 2026, an estimated $33.2K.
Quest Diagnostics made up 0.16% of American National Bank & Trust's portfolio in Q2 2026, its #76 holding.
American National Bank & Trust first reported a position in Quest Diagnostics in Q2 2024 and has held it in 7 quarters since.
American National Bank & Trust's Quest Diagnostics position peaked at $1.93M in Q3 2025.
353 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.